Malignant Transformation of Heterotopic Pancreatic Tissue in a Patient with BRCA2 Mutation
Gastroenterology Insights · 2021
DOI: 10.3390/gastroent12010002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology Insights, 2021. Verfasst von Danson Xue Wei Yeo und 6 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Malignant transformation of heterotopic pancreatic tissue is a rare entity with only several case reports published in the scientific literature. Adjuvant chemotherapy following oncological resection for lesions with nodal metastasis has not been well described and there are no guidelines available to guide the management of these patients. Case Presentation: We present a case of gastric heterotopic pancreatic carcinoma with nodal metastasis in a young patient with breast cancer gene (BRCA) 2 mutation. He had undergone a laparoscopic wedge resection for a gastric lesion initially thought to be a gastrointestinal stroma tumor. Given the involvement of the wedge resection margins, the patient underwent a distal gastrectomy with oncological lymph nodal clearance. One out of the 33 harvested lymph nodes harboured micrometastasis while the main gastrectomy specimen did not have any residual malignancy. Following the histological diagnosis, he received an adjuvant chemotherapy regime akin to that prescribed for locally advanced pancreatic adenocarcinoma with good response. This is, to our knowledge, also the first such case report in a patient with BRCA2 mutation.
Conclusions
Pre-operative diagnostic confirmation is challenging and endoscopic procedures pose significant false negatives. Reports of nodal metastasis following oncological resection are limited and there are no guidelines regarding adjuvant therapies. We would recommend a chemotherapy regimen similar to that for primary locally advanced pancreatic carcinoma in patients found to have nodal metastasis.
Zitieren
APA
Yeo, D. X. W., Goh, N., Chuah, K. L., Amitbhai, S. K., Oo, A. M., Ahmed, A. K. S., & Nath, K. A. (2021). Malignant Transformation of Heterotopic Pancreatic Tissue in a Patient with BRCA2 Mutation. Gastroenterology Insights. https://doi.org/10.3390/gastroent12010002
Vancouver
Yeo DXW, Goh N, Chuah KL, Amitbhai SK, Oo AM, Ahmed AKS, et al. Malignant Transformation of Heterotopic Pancreatic Tissue in a Patient with BRCA2 Mutation. Gastroenterology Insights. 2021. doi:10.3390/gastroent12010002
BibTeX
@article{Yeo2021,
author = {Yeo, Danson Xue Wei and Goh, Nicholette and Chuah, Khoon Leong and Amitbhai, Sanghvi Kaushal and Oo, Aung Myint and Ahmed, Abdul Kareem Saleem and Nath, Koura Aaryan},
title = {Malignant Transformation of Heterotopic Pancreatic Tissue in a Patient with BRCA2 Mutation},
journal = {Gastroenterology Insights},
year = {2021},
doi = {10.3390/gastroent12010002}
}
EUVIMED